Benign prostatic hyperplasia (BPH), also called prostate gland enlargement, is very common in older men. By age 60, over one-half of men have BPH; by age 85, the number climbs to 90%, according to the American Urological Association (AUA). An enlarged prostate gland can cause uncomfortable urinary symptoms, such as increased urges to urinate, especially at night. It can also cause bladder, urinary tract, or kidney problems.
There are various treatment options for BPH, depending on the patient’s symptoms, prostate size, and other health conditions.
Busch Center highly recommends TUSLA (Transurethral Directional High-Intensity Ultrasound Ablation) to treat BPH. TULSA technology works by delivering precise/directional doses of high-intensity ultrasound waves to destroy enlarged prostate tissue while actively protecting surrounding healthy tissue.
Busch Center uses state-of-the-art MRI imaging throughout the procedure to deliver incision-free, targeted ablation of excessive prostate tissue, using advanced MRI technology to provide precision and accuracy. This customizable treatment option results in positive outcomes while preserving men’s quality of life (e.g., urinary continence, erectile function).
TULSA offers significant benefits, including:
- Positive outcomes
- No radiation
- Outpatient procedure
- Minimal recovery time
Dr. Busch is one of the few physicians in the U.S. trained to perform the revolutionary TULSA treatment method to treat both prostate cancer and BPH.
Other BPH treatments are not as accurate and may cause significant side effects:
- TURP. Transurethral resection of the prostate (TURP) uses an electrical loop to cut excess prostate tissue. After this procedure, patients may have problems emptying their bladder. Additionally, TURP’s electrical loop sometimes damages the urethra, a side effect avoided by TULSA.
- Aqua Ablation. Aqua Ablation uses a high-pressure stream of sterile saline to destroy excess prostate tissue. This option typically requires an overnight hospital stay, whereas TULSA is an outpatient procedure at Busch Center. Per recent AUA guidelines, Aqua Ablation can only be offered to men with prostates measuring less than 80cc. For comparison, TULSA can treat men with a significantly larger (up to a 250 cc) prostate.
- Urolift. Urolift is yet another treatment option for BPH, that may have considerable, negative impact on a man’s health. Certain factors, such as a large median lobe, may limit this procedure’s effectiveness. Also, noteworthy: once a man gets a Urolift, he cannot have a subsequent TULSA procedure due to the metal in the Urolift.
Busch Center is proud to be the first facility in the southeast United States to offer groundbreaking, non-invasive TULSA technology. Now, Dr. Busch uses this innovative methodology to successfully treat prostate cancer and BPH patients with no surgery, radiation, or side effects.